|  |  | 

India Top Headlines

Covaxin Test for Age Group 2-18 Will Begin in 10-12 Days, Government Says | India News


NEW DELHI: Bharat Biotech’s Covaxin trial in the 2- to 18-year-old age group is likely to begin in the next 10 to 12 days. This was stated today by VK Paul, a member of NITI Aayog (Health) while speaking to the media today.
The Comptroller General of Medicines of India (DCGI) last week approved Covaxin for Phase II / III clinical trials in that age group.
Speaking about the use of DRDO’s Covid 2DG drug, Paul said: “We will examine the drug in the National Covid-19 Task Force to add it to the treatment protocol.” The drug already has DCGI approval for emergency use in Covid patients.
Speaking at the same event, health ministry official Luv Agarwal said that 1.8% of India’s total population has been affected by the disease so far. That means that almost 98% of people are still vulnerable to infection.
Commenting on current infection and recovery trends, Agarwal reported that 199 districts have shown a continuous decline in cases and positivity since the last 3 weeks.
8 states now have more than 1 lakh of active cases, 10 states have 50,000-1.00.00 and 18 have less than 50,000.
The overall positivity rate in the country now stands at 14.10%.
The recovery rate has also improved from 81.7% on My 3 to 85.6% now, with the number of recoveries crossing 4 lakh for the first time yesterday, Agarwal said.

Original source